EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment

Frederike Stöth iD, Wolfgang Weinmann, Leila Maria Soravia, Philippe Pfeifer

Alcohol and Alcoholism · 09.05.2023 · 58 (3) · 266-273

DOI: 10.1093/alcalc/agad010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alcohol and Alcoholism, online erschienen am 09.03.2023. Verfasst von Frederike Stöth und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Forensic Medicine, Forensic Toxicology and Chemistry, University of Bern, Murtenstrasse 26, 3008 Bern, Switzerland. Hauptthemen laut MEDLINE: Alcoholism. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Swiss Foundation for Alcohol Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Phosphatidylethanol (PEth) is used to monitor alcohol consumption in alcohol use disorder (AUD). In this study, we aim to evaluate the elimination time of PEth with regard to the clinically established 200 and 20 ng/ml cutoffs for PEth 16:0/18:1.

Methods

Data from 49 patients undergoing treatment for AUD were evaluated. PEth concentrations were measured at the beginning and repeatedly during the treatment period of up to 12 weeks to monitor the elimination of PEth. We evaluated the time in weeks until the cutoff concentrations of <200 and <20 ng/ml were achieved. The correlation between the initial PEth concentration and the number of days until the PEth concentration had dropped below 200 and 20 ng/ml was assessed by calculating Pearson’s correlation coefficients.

Results

The initial PEth concentrations ranged from <20 to >2500 ng/ml. In 31 patients, the time until the cutoff values were reached could be documented. Even after 6 weeks of abstinence, PEth concentrations above the cutoff of 200 ng/ml could still be detected in two patients. A strong significant positive correlation was found between the initial PEth concentration and the time required to drop below the two cutoffs.

Conclusion

A waiting period of more than 6 weeks after declared abstinence should be granted for individuals with AUD before using only one single PEth concentration to assess the consumption behavior. However, we recommend to always use at least two PEth concentrations for the evaluation of alcohol-drinking behaviors in AUD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismHumansAlcohol DrinkingGlycerophospholipids

Substanzen

phosphatidylethanolGlycerophospholipids

Autor:innen und Institutionen

  • Institute of Forensic Medicine, Forensic Toxicology and Chemistry, University of Bern, Murtenstrasse 26, 3008 Bern, Switzerland.
  • Graduate School for Cellular and Biomedical Sciences, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland.
  • Klinik Südhang, Südhang 1, 3038 Kirchlindach, Switzerland.
  • University Hospital of Psychiatry, University of Bern, Bolligenstrasse 111, 3000 Bern, Switzerland.

ORCID-Profile: Frederike Stöth

Förderung

  • Swiss Foundation for Alcohol Research

Zitieren

APA

Stöth, F., Weinmann, W., Soravia, L. M., & Pfeifer, P. (2023). Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment. Alcohol and Alcoholism, 58(3), 266-273. https://doi.org/10.1093/alcalc/agad010

Vancouver

Stöth F, Weinmann W, Soravia LM, Pfeifer P. Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment. Alcohol and Alcoholism. 2023;58(3):266-273. doi:10.1093/alcalc/agad010

BibTeX
@article{Stth2023,
  author = {Stöth, Frederike and Weinmann, Wolfgang and Soravia, Leila Maria and Pfeifer, Philippe},
  title = {Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment},
  journal = {Alcohol and Alcoholism},
  year = {2023},
  volume = {58},
  number = {3},
  pages = {266--273},
  doi = {10.1093/alcalc/agad010}
}
Kostenlos starten →